HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deciding who to treat with biologic disease-modifying antirheumatic drugs in axial spondyloarthritis.

AuthorsDaniel Wendling, Philippe Goupille
JournalImmunotherapy (Immunotherapy) Vol. 12 Issue 12 Pg. 857-860 (08 2020) ISSN: 1750-7448 [Electronic] England
PMID32635788 (Publication Type: Editorial)
Chemical References
  • Antirheumatic Agents
  • Biological Products
Topics
  • Antirheumatic Agents (therapeutic use)
  • Biological Products (therapeutic use)
  • Humans
  • Patient Selection
  • Spondylarthritis (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: